Clinical trials
Not yet recruiting Phase 1/2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
215 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 13 |
| 2025 | 66 |
| 2026 | 112 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 215 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 27 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 5 |
| Fudan University | 4 |
| Ruijin Hospital | 4 |
| Sinocelltech Ltd. | 4 |
| Sun Yat-sen University | 4 |
| Akeso | 3 |
| FutureGen Biopharmaceutical (Beijing) Co., Ltd | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| Peking Union Medical College Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 8 |
| Pancreatic Neoplasms | 6 |
| Recurrence | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Multiple Myeloma | 5 |
| Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Hepatocellular | 4 |
Trials
Showing 1 to 25 of 215. Each trial links to its page on Pharma Observatory.
115 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.